Gösta Gahrton

Publications
CV
Public outreach and news

Articles

Article: CANCER MEDICINE. 2023;12(22):20736-20744

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.

Nahi H; Afram G; Uttervall K; Lockmer S; Tätting L; Gahrton G; Kashif M; Alici E; Stromberg O; Klimkowska M; Lund J
Journal article: HAEMATOLOGICA. 2023;108(10):2568-2569

CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?

Gahrton G
Journal article: HEMATOLOGY JOURNAL. 2023

CAR-T cell treatment of high-risk multiple myeloma – will there be a cure?

Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(5):258.e1-258.e8

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment.

Reinoso-Segura M; Caballero-Velázquez T; Herrera P; Patriarca F; Fanin R; Bruno B; Einsele H; Nahi H; Granell M; López-Corral L; Reguera JL; García-Cadenas I; Gahrton G; Pérez-Simón JA; European Myeloma Network, the European Society for
Article: CELL REPORTS MEDICINE. 2022;3(2):100508

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.

Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellström K; Liwing J; Gustafsson C; Månsson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: BLOOD CANCER JOURNAL. 2021;11(12):192

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.

Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554

Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.

Afram G; Susek KH; Uttervall K; Wersäll JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1810-1816

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation.

Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):588-596

Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?

Gran C; Uttervall K; Borg Bruchfeld J; Wallblom A; Alici E; Gahrton G; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(3):247-254

Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma.

Uttervall K; Borg Bruchfeld J; Gran C; Wålinder G; Månsson R; Lund J; Gahrton G; Alici E; Nahi H
Article: PLOS ONE. 2019;14(2):e0211927

Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma.

Nahi H; Chrobok M; Gran C; Lund J; Gruber A; Gahrton G; Ljungman P; Wagner AK; Alici E
Journal article: BLOOD. 2018;132(Supplement 1):3464

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Itälä-Remes M; Blaise D; Niederwieser D; Meijer E; Petersen EJ; de Wreede LC; Ljungman P; Bourhis J-H; Veelken H; Beelen DW; Stelljes M; Gerbitz A; Ceballos P; Finke J; Passweg JR; Milpied N-J; Bornhäuser M; Yakoub-Agha I; Schönland S; Garderet L; Kroeger N
Article: CANCER MEDICINE. 2018;7(6):2256-2268

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma.

Lund J; Gruber A; Lauri B; Duru AD; Blimark C; Swedin A; Hansson M; Forsberg K; Ahlberg L; Carlsson C; Waage A; Gimsing P; Vangsted AJ; Frølund U; Holmberg E; Gahrton G; Alici E; Hardling M; Mellqvist U-H; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(4):386-388

Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients.

Gran C; Gahrton G; Alici E; Nahi H
Article: LEUKEMIA & LYMPHOMA. 2017;58(4):797-808

Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.

Garderet L; Cook G; Auner HW; Bruno B; Lokhorst H; Perez-Simon JA; Sahebi F; Scheid C; Morris C; van Biezen A; Sobh M; Michallet M; Gahrton G; Schönland S; Kröger N
Article: LEUKEMIA. 2016;30(10):2047-2054

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party.

Sobh M; Michallet M; Gahrton G; Iacobelli S; van Biezen A; Schönland S; Petersen E; Schaap N; Bonifazi F; Volin L; Meijer E; Niederwieser D; El Cheikh J; Tabrizi R; Fegeux N; Finke J; Bunjes D; Cornelissen J; Einsele H; Bruno B; Potter M; Fanin R; Mohty M; Garderet L; Kröger N
Article: ANNALS OF HEMATOLOGY. 2016;95(6):967-972

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.

Gratwohl A; Iacobelli S; Bootsman N; van Biezen A; Baldomero H; Arcese W; Arnold R; Bron D; Cordonnier C; Ernst P; Ferrant A; Frassoni F; Gahrton G; Richard C; Kolb HJ; Link H; Niederwieser D; Ruutu T; Schattenberg A; Schmitz N; Torres-Gomez A; Zwaan F; Apperley J; Olavarria E; Kröger N; Chronic Malignancies Working Party of the European
Article: LEUKEMIA & LYMPHOMA. 2016;57(1):183-192

A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells.

Cardona ME; Simonson OE; Oprea II; Moreno PMD; Silva-Lara MF; Mohamed AJ; Christensson B; Gahrton G; Dilber MS; Smith CIE; Arteaga HJ
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(1):46-54

Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.

Nahi H; Våtsveen TK; Lund J; Heeg BMS; Preiss B; Alici E; Møller MB; Wader KF; Møller HEH; Grøseth LA; Østergaard B; Dai HY; Holmberg E; Gahrton G; Waage A; Abildgaard N
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(12):2039-2051

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):808-812

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

Grövdal M; Nahi H; Gahrton G; Liwing J; Waage A; Abildgaard N; Pedersen PT; Hammerstrøm J; Laaksonen A; Bazia P; Terava V; Ollikainen H; Silvennoinen R; Putkonen M; Anttila P; Porkka K; Remes K
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):802-807

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.

Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NPM; López-Corral L; Poire X; Passweg J; Hamljadi R-M; Thomas SH; Schonland S; Gahrton G; Morris C; KrÖger N; Garderet L
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(6):1054-1058

Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.

Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji R-M; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T
Article: BONE MARROW TRANSPLANTATION. 2015;50(4):505-510

Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.

Iacobelli S; de Wreede LC; Schönland S; Björkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kröger N; Gahrton G; EBMT CMWP, Plasma Cell Disorders Subcommittee
Article: PLOS ONE. 2015;10(9):e0138248

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2014;164(5):684-693

Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population.

Liwing J; Uttervall K; Lund J; Aldrin A; Blimark C; Carlson K; Enestig J; Flogegård M; Forsberg K; Gruber A; Haglöf Kviele H; Johansson P; Lauri B; Mellqvist U-H; Swedin A; Svensson M; Näsman P; Alici E; Gahrton G; Aschan J; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;92(1):19-25

Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma--a retrospective population based study of 1162 patients.

Lund J; Uttervall K; Liwing J; Gahrton G; Alici E; Aschan J; Holmberg E; Nahi H
Article: PLOS ONE. 2014;9(7):e101819

The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.

Uttervall K; Duru AD; Lund J; Liwing J; Gahrton G; Holmberg E; Aschan J; Alici E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2013;48(11):1395-1400

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation.

Auner HW; Szydlo R; van Biezen A; Iacobelli S; Gahrton G; Milpied N; Volin L; Janssen J; Nguyen Quoc S; Michallet M; Schoemans H; El Cheikh J; Petersen E; Guilhot F; Schönland S; Ahlberg L; Morris C; Garderet L; de Witte T; Kröger N; Plasma Cell Dyscrasia Sub-committee of the Chronic
Article: BLOOD. 2013;121(25):5055-5063

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

Gahrton G; Iacobelli S; Björkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Schönland S; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kröger N; EBMT Chronic Malignancies Working Party Plasma Cel
Article: LEUKEMIA. 2012;26(1):149-157

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Kumar SK; Lee JH; Lahuerta JJ; Morgan G; Richardson PG; Crowley J; Haessler J; Feather J; Hoering A; Moreau P; LeLeu X; Hulin C; Klein SK; Sonneveld P; Siegel D; Bladé J; Goldschmidt H; Jagannath S; Miguel JS; Orlowski R; Palumbo A; Sezer O; Rajkumar SV; Durie BGM; International Myeloma Working Group
Article: LAKARTIDNINGEN. 2011;108(45):2261

[Palliative care. Allow active euthanasia when there is no hope of cure].

Gahrton G
Article: BLOOD. 2011;118(12):3205-3211

Approach to the treatment of multiple myeloma: a clash of philosophies.

Rajkumar SV; Gahrton G; Bergsagel PL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(22):3016-3022

Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.

Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
Article: BLOOD. 2011;117(23):6063-6073

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Cavo M; Rajkumar SV; Palumbo A; Moreau P; Orlowski R; Bladé J; Sezer O; Ludwig H; Dimopoulos MA; Attal M; Sonneveld P; Boccadoro M; Anderson KC; Richardson PG; Bensinger W; Johnsen HE; Kroeger N; Gahrton G; Bergsagel PL; Vesole DH; Einsele H; Jagannath S; Niesvizky R; Durie BGM; San Miguel J; Lonial S; International Myeloma Working Group
Article: BLOOD. 2011;117(18):4691-4695

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

Rajkumar SV; Harousseau J-L; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J; International Myeloma Workshop Consensus Panel 1
Article: RECENT RESULTS IN CANCER RESEARCH. 2011;183:273-284

Allogeneic transplantation in multiple myeloma.

Gahrton G
Article: LEUKEMIA RESEARCH. 2010;34(12):1627-1629

Constitutional inv(3) in myelodysplastic syndromes.

Gahrton C; Nahi H; Jansson M; Wallblom A; Alici E; Sutlu T; Samuelsson J; Gahrton G
Article: CYTOTHERAPY. 2010;12(8):1044-1055

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.

Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
Article: HAEMATOLOGICA. 2010;95(12):2126-2133

Efficacy and outcome of autologous transplantation in rare myelomas.

Morris C; Drake M; Apperley J; Iacobelli S; van Biezen A; Bjorkstrand B; Goldschmidt H; Harousseau J-L; Morgan G; de Witte T; Niederwieser D; Gahrton G; Myeloma Subcommittee of Chronic Leukaemia Working
Article: HUMAN GENE THERAPY. 2010;21(8):929-941

TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy.

Preuss E; Treschow A; Newrzela S; Brücher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
Article: HAEMATOLOGICA. 2010;95(5):804-809

Primary plasma cell leukemia and autologous stem cell transplantation.

Drake MB; Iacobelli S; van Biezen A; Morris C; Apperley JF; Niederwieser D; Björkstrand B; Gahrton G; European Group for Blood and Marrow Transplantatio
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(2):323-331

Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.

Kröger N; Shimoni A; Schilling G; Schwerdtfeger R; Bornhäuser M; Nagler A; Zander AR; Heinzelmann M; Brand R; Gahrton G; Morris C; Niederwieser D; de Witte T
Article: LEUKEMIA. 2009;23(10):1904-1912

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Richardson PG; Niesvizky R; Rajkumar SV; Durie BGM; IMWG
Article: ONCOLOGY REPORTS. 2009;22(1):137-142

Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation.

Paul E; Sutlu T; Deneberg S; Alici E; Björkstrand B; Jansson M; Lerner R; Wallblom A; Gahrton G; Nahi H
Article: BLOOD. 2008;111(6):3155-3162

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E; Sutlu T; Björkstrand B; Gilljam M; Stellan B; Nahi H; Quezada HC; Gahrton G; Ljunggren H-G; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2007;35(12):1839-1846

Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.

Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren H-G; Dilber MS
Article: HAEMATOLOGICA. 2007;92(11):1513-1518

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.

Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D; Myeloma Subcommittee of the EBMT
Article: SEMINARS IN HEMATOLOGY. 2007;44(4):227-233

High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future.

Björkstrand B; Gahrton G
Article: HAEMATOLOGICA. 2007;92(8):1083-1090

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.

Bourhis J-H; Bouko Y; Koscielny S; Bakkus M; Greinix H; Derigs G; Salles G; Feremans W; Apperley J; Samson D; Björkstrand B; Niederwieser D; Gahrton G; Pico J-L; Goldschmidt H; European Group for Blood and Marrow Transplantatio
Article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2007;20(2):219-229

Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation.

Gahrton G
Article: BLOOD. 2007;109(8):3588-3594

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.

Crawley C; Iacobelli S; Björkstrand B; Apperley JF; Niederwieser D; Gahrton G
Article: CANCER GENE THERAPY. 2007;14(3):227-232

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.

Alici E; Björkstrand B; Treschow A; Aints A; Smith CIE; Gahrton G; Dilber MS
Article: LEUKEMIA. 2006;20(9):1467-1473

International uniform response criteria for multiple myeloma.

Durie BGM; Harousseau J-L; Miguel JS; Bladé J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Cavo M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV; International Myeloma Working Group
Article: LEUKEMIA & LYMPHOMA. 2006;47(9):1768-1773

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.

Olsson-Strömberg U; Höglund M; Björkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Löfvenberg E; Malm C; Nilsson P-G; Paul C; Rödjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY. 2006;4(5):388-391

Pro: allogeneic transplantation in multiple myeloma.

Gahrton G
Article: BLOOD. 2006;107(6):2578-2584

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

Schönland SO; Lokhorst H; Buzyn A; Leblond V; Hegenbart U; Bandini G; Campbell A; Carreras E; Ferrant A; Grommisch L; Jacobs P; Kröger N; La Nasa G; Russell N; Zachee P; Goldschmidt H; Iacobelli S; Niederwieser D; Gahrton G; Chronic Leukemia Working Party; Myeloma Subcommittee of the European Cooperative G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;62(5):429-436

Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines.

Arteaga HJ; Mohamed AJ; Christensson B; Mahdy E; Gahrton G; Smith CIE; Dilber MS
Article: CURRENT OPINION IN HEMATOLOGY. 2005;12(6):463-470

Progress in hematopoietic stem cell transplantation in multiple myeloma.

Gahrton G
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(8):883-893

Identification of progression markers in B-CLL by gene expression profiling.

Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Article: BLOOD. 2005;106(2):681-689

Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia.

Fält S; Merup M; Tobin G; Thunberg U; Gahrton G; Rosenquist R; Wennborg A
Article: BLOOD. 2005;105(11):4532-4539

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

Crawley C; Lalancette M; Szydlo R; Gilleece M; Peggs K; Mackinnon S; Juliusson G; Ahlberg L; Nagler A; Shimoni A; Sureda A; Boiron J-M; Einsele H; Chopra R; Carella A; Cavenagh J; Gratwohl A; Garban F; Zander A; Björkstrand B; Niederwieser D; Gahrton G; Apperley JF; Chromic Leukaemia Working Party of the EBMT
Article: BONE MARROW TRANSPLANTATION. 2005;35(6):609-617

The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.

Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
Article: BONE MARROW TRANSPLANTATION. 2005;35(1):37-43

Stem cell transplantation from identical twins in patients with myelodysplastic syndromes.

Kröger N; Brand R; van Biezen A; Bron D; Blaise D; Hellström-Lindberg E; Gahrton G; Powles R; Littlewood T; Chapuis B; Zander A; Koza V; Niederwieser D; de Witte T; Myelodysplastic Syndromes Subcommittee of the Chro
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162

Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.

Simonsson B; Oberg G; Bjoreman M; Bjorkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Lofvenberg E; Malm C; Olsson K; Olsson-Stromberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén A-M; Wahlin A; Vilén L; Weis-Bjerrum O
Article: HUMAN MOLECULAR GENETICS. 2004;13(23):2925-2936

Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia.

Hammarsund M; Lerner M; Zhu C; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grandér D; Sangfelt O; Corcoran M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(9):1674-1681

Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study.

Morris C; Iacobelli S; Brand R; Bjorkstrand B; Drake M; Niederwieser D; Gahrton G; Chronic Leukaemia Working Party Myeloma Subcommitt
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466

Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.

Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén A-M; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Oberg G; Swedish CML Study Group
Article: LEUKEMIA. 2003;17(9):1827-1833

No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

Hast R; Hellström-Lindberg E; Ohm L; Björkholm M; Celsing F; Dahl I-M; Dybedal I; Gahrton G; Lindberg G; Lerner R; Linder O; Löfvenberg E; Nilsson-Ehle H; Paul C; Samuelsson J; Tangen J-M; Tidefelt U; Turesson I; Wahlin A; Wallvik J; Winquist I; Oberg G; Bernell P
Article: BLOOD. 2003;102(5):1927-1929

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.

Corradini P; Cavo M; Lokhorst H; Martinelli G; Terragna C; Majolino I; Valagussa P; Boccadoro M; Samson D; Bacigalupo A; Russell N; Montefusco V; Voena C; Gahrton G; Chronic Leukemia Working Party of the European Gro
Article: BONE MARROW TRANSPLANTATION. 2003;32(2):121-124

The World Marrow Donor Association (WMDA): its goals and activities.

Gahrton G; van Rood JJ; Oudshoorn M; World Marrow Donor Association (WMDA)
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;121(5):749-757

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

International Myeloma Working Group
Article: HUMAN GENE THERAPY. 2002;13(17):2085-2110

Opinion paper on the current status of the regulation of gene therapy in Europe.

Cohen-Haguenauer O; Rosenthal F; Gänsbacher B; Bolhuis R; Dorsch-Häsler K; Eshhar Z; Gahrton G; Hokland P; Melani C; Rankin E; Thielemans K; Vile R; Zwierzina H; Cichutek K; Euregenethy Network
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2002;68(6):376-381

Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy.

Oberg G; Killander A; Björeman M; Gahrton G; Grimfors G; Gruber A; Hast R; Lerner R; Liliemark J; Mattson S; Paul C; Simonsson B; Stalfelt A-M; Stenke L; Tidefelt U; Udén A-M; Björkholm M; LGMS
Article: GENE THERAPY. 2001;8(14):1051-1056

Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting.

Aints A; Güven H; Gahrton G; Smith CI; Dilber MS
Article: CYTOKINE. 2001;14(3):136-142

Expression and release of stable and active forms of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments.

Arteaga HJ; Mohamed AJ; Christensson B; Gahrton G; Smith CI; Dilber MS
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2001;67(1):20-26

Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells.

Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CI; Dilber MS
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(1):209-216

Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell NH; Samson D; Schaefer UW; Schattenberg A; Tura S; Verdonck LF; Vernant JP; Willemze R; Volin L; European Group for Blood and Marrow Transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):511-515

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT).

Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
Article: GENOMICS. 2000;70(3):327-334

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.

Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
Article: LEUKEMIA. 2000;14(1):112-118

Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia.

Lindquist R; Forsblom AM; Ost A; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 1999;24(7):741-745

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.

Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
Article: GENOMICS. 1999;60(2):161-171

Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates.

Wu X; Ivanova G; Merup M; Jansson M; Stellan B; Grandér D; Zabarovsky E; Gahrton G; Einhorn S
Article: PATHOLOGIE ET BIOLOGIE. 1999;47(2):188-191

Allogeneic bone marrow transplantation in multiple myeloma.

Gahrton G
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935

Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.

Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: LANCET. 1998;352(9134):1087-1092

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Gratwohl A; Hermans J; Goldman JM; Arcese W; Carreras E; Devergie A; Frassoni F; Gahrton G; Kolb HJ; Niederwieser D; Ruutu T; Vernant JP; de Witte T; Apperley J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1998;102(5):1115-1123

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Bladé J; Samson D; Reece D; Apperley J; Björkstrand B; Gahrton G; Gertz M; Giralt S; Jagannath S; Vesole D
Article: LEUKEMIA. 1998;12(5):705-709

A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia--comparison with cytogenetics and Southern hybridization.

Merup M; Jansson M; Corcoran M; Liu Y; Wu X; Rasool O; Stellan B; Hermansson M; Juliusson G; Gahrton G; Einhorn S
Article: BLOOD. 1998;91(9):3397-3400

6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas.

Merup M; Moreno TC; Heyman M; Rönnberg K; Grandér D; Detlofsson R; Rasool O; Liu Y; Söderhäll S; Juliusson G; Gahrton G; Einhorn S
Article: ANTICANCER RESEARCH. 1998;18(2A):759-767

Production of a motility factor by a newly established lung adenocarcinoma cell line.

Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
Article: BLOOD. 1998;91(4):1382-1390

Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia.

Corcoran MM; Rasool O; Liu Y; Iyengar A; Grander D; Ibbotson RE; Merup M; Wu X; Brodyansky V; Gardiner AC; Juliusson G; Chapman RM; Ivanova G; Tiller M; Gahrton G; Yankovsky N; Zabarovsky E; Oscier DG; Einhorn S
Article: LEUKEMIA. 1997;11(12):2105-2110

Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patients.

Haglund U; Stellan B; Juliusson G; Gahrton G
Article: GENES CHROMOSOMES & CANCER. 1997;20(4):337-346

Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint.

Wu X; Merup M; Juliusson G; Jansson M; Stellan B; Grandér D; Zabarovsky E; Liu Y; Spasokoukotskaja T; Gahrton G; Einhorn S
Article: ONCOGENE. 1997;15(20):2463-2473

Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.

Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grandér D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu X; Gardiner A; Mullenbach R; Poltaraus A; Hultström AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
Article: BONE MARROW TRANSPLANTATION. 1997;20(7):553-560

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
Article: CANCER RESEARCH. 1997;57(8):1523-1528

Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo.

Dilber MS; Abedi MR; Christensson B; Björkstrand B; Kidder GM; Naus CC; Gahrton G; Smith CI
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;58(3):174-180

Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia.

Merup M; Juliusson G; Wu X; Jansson M; Stellan B; Rasool O; Röijer E; Stenman G; Gahrton G; Einhorn S
Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 1997;11(1):147-157

Allogeneic stem cell transplantation for multiple myeloma.

Bensinger WI; Buckner D; Gahrton G
Article: BLOOD. 1996;88(12):4711-4718

Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation.

Björkstrand BB; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Bladé J; Carlson K; Cavo M; Ferrant A; Goldstone AH; de Laurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;95(3):494-500

Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Gratwohl A; Hermans J; van Biezen A; Arcese W; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G; Iriondo A; Kolb HJ; Link H; Niederwieser D; Ruutu T; Siegert W; Zwaan FE
Article: BLOOD. 1996;88(6):2192-2200

Suicide gene therapy for plasma cell tumors.

Dilber MS; Abedi MR; Björkstrand B; Christensson B; Gahrton G; Xanthopoulos KG; Smith CI
Article: EUROPEAN JOURNAL OF CANCER. 1996;32A(8):1300-1302

Cancer research in the European community--report from a meeting in Stockholm in 1995.

Gahrton G; Graessman A; Meunier F; Schitt M; Van Dongen JJ; Baig SS
Article: BONE MARROW TRANSPLANTATION. 1996;17(5):759-762

Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMT.

Samson D; Volin L; Schanz U; Bosi A; Gahrtron G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(3):647-652

Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Article: ANNALS OF INTERNAL MEDICINE. 1996;124(3):311-315

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

Michallet M; Archimbaud E; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Rozman C; Gratwohl A; Gale RP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(2):251-254

Allogeneic bone marrow transplantation in multiple myeloma.

Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(1):35-43

Indications for haemopoietic precursor cell transplants in Europe. European Group for Blood and Marrow Transplantation (EBMT).

Gratwohl A; Hermans J; Baldomero H; Tichelli A; Goldman JM; Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(5):302-306

Retroviral-mediated gene transfer into human bone marrow stromal cells: studies of efficiency and in vivo survival in SCID mice.

Li KJ; Dilber MS; Abedi MR; Björkstrand B; Smith CI; Garoff H; Gahrton G; Xanthopoulos KG
Article: BLOOD. 1995;86(5):1911-1915

13q deletions in lymphoid malignancies.

Liu Y; Hermanson M; Grandér D; Merup M; Wu X; Heyman M; Rasool O; Juliusson G; Gahrton G; Detlofsson R; Nikiforova N; Buys C; Söderhäll S; Yankovsky N; Zabarovsky E; Einhorn S
Article: BLOOD. 1995;86(4):1614-1618

Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.

Ljungman P; Johansson N; Aschan J; Glaumann H; Lönnqvist B; Ringdén O; Sparrelid E; Sönnerborg A; Winiarski J; Gahrton G
Article: STEM CELLS. 1995;13 Suppl 2:140-146

Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation.

Björkstrand B; Ljungman P; Bird JM; Samson D; Brandt L; Alegre A; Auzanneau G; Bladé J; Brunet S; Carlson K
Article: STEM CELLS. 1995;13 Suppl 2:122-125

An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.

Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Article: BLOOD. 1995;86(2):813-818

Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.

Gratwohl A; Hermans J; Apperley J; Arcese W; Bacigalupo A; Bandini G; di Bartolomeo P; Boogaerts M; Bosi A; Carreras E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23

Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison.

Björkholm M; Liliemark J; Gahrton G; Grimfors G; Gruber A; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(6):1312-1322

Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625

Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.

Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):367-371

Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma.

Björkstrand B; Ljungman P; Bird JM; Samson D; Gahrton G
Article: LAKARTIDNINGEN. 1995;92(9):849-853

[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].

Ljungman P; Björkstrand B; Gahrton G; Nordenström J; Shanwell A; Glas U; Rotstein S; Rutqvist LE; Wilking N
Show more

All other publications

Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225

Response to Caravita di Toritto and Rago.

Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Conference publication: BLOOD. 2022;140:2126-2129

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Niederwieser D; Hasenclever D; Berdel WE; Biemond BJ; Al-Ali HK; Chalandon Y; Van Gelder M; Junghanss C; Gahrton G; Haenel M; Hehlmann R; Heinicke T; Hochhaus A; Iacobelli S; Kooy RVM; Kroger N; Janssen JJWM; Jentzsch M; Breywisch F; Mohty M; Masouridi-Levrat S; Ossenkoppele G; Passweg J; Poenisch W; Schetelig J; Schliemann C; Schwind S; Stelljes M; Valk PJM; Lowenberg B; Cornelissen JJ
Meeting abstract: BLOOD. 2021;138:4796

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Nahi H; Chrobook M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Walther-Jallow L; Liwing J; Klimkowska M; Gahrton G; Ljungman P; Ljunggren H-G; Alici E
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(3):496-507

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.

Rosiñol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos M-A; Dispenzieri A; Einsele H; Engelhardt M; Fernández de Larrea C; Gahrton G; Gay F; Hájek R; Hungria V; Jurczyszyn A; Kröger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Bladé J
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(9):1559-1566

Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT.

Garderet L; Morris C; Beksac M; Gahrton G; Schönland S; Yakoub-Agha I; Hayden PJ
Review: JOURNAL OF CLINICAL MEDICINE. 2020;9(7):E2180-2180

Allogeneic Transplantation in Multiple Myeloma-Does It Still Have a Place?

Gahrton G; Iacobelli S; Garderet L; Yakoub-Agha I; Schönland S
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(5):e213-e217

Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT.

Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhäuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schönland S; Yakoub-Agha I; Kröger N
Conference publication: BLOOD. 2019;134:259

Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up

Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E170

Novel RNA construct increases cytotoxic proteins in lymphocytes and leads to prolonged survival in an experimental syngeneic immunocompetent Multiple Myeloma model

Wagner AK; Baloch AH; Chrobok M; Dahlberg C; Gahrton G; Nahi H; Ljunggren H-G; Alici E
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E206

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma - Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation

Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Niittyvoupio R; Blaise D; Niederwieser D; Meier E; Petersen E; de Wreede LC; Ljungman P; Bourhis JH; Veelken H; Beelen D; Stelljes M; Gerbitz A; Vincent L; Finke J; Passweg J; Milpied N; Stoelzel F; Yakoub-Agha I; Schoenland S; Garderet L; Kroger N
Editorial comment: LANCET HAEMATOLOGY. 2017;4(6):e250-e251

Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma.

Gahrton G
Review: LEUKEMIA & LYMPHOMA. 2016;57(6):1256-1268

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting).

Bruno B; Auner HW; Gahrton G; Garderet L; Festuccia M; Ladetto M; Lemoli RM; Massaia M; Morris C; Palumbo A; Schönland S; Boccadoro M; Kröger N
Review: LEUKEMIA. 2016;30(5):1005-1017

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Laubach J; Garderet L; Mahindra A; Gahrton G; Caers J; Sezer O; Voorhees P; Leleu X; Johnsen HE; Streetly M; Jurczyszyn A; Ludwig H; Mellqvist U-H; Chng W-J; Pilarski L; Einsele H; Hou J; Turesson I; Zamagni E; Chim CS; Mazumder A; Westin J; Lu J; Reiman T; Kristinsson S; Joshua D; Roussel M; O'Gorman P; Terpos E; McCarthy P; Dimopoulos M; Moreau P; Orlowski RZ; Miguel JS; Anderson KC; Palumbo A; Kumar S; Rajkumar V; Durie B; Richardson PG
Review: EXPERT REVIEW OF HEMATOLOGY. 2014;7(1):79-90

Allogeneic transplantation in multiple myeloma.

Gahrton G; Krishnan A
Review: LEUKEMIA. 2014;28(2):269-277

IMWG consensus on risk stratification in multiple myeloma.

Chng WJ; Dispenzieri A; Chim C-S; Fonseca R; Goldschmidt H; Lentzsch S; Munshi N; Palumbo A; Miguel JS; Sonneveld P; Cavo M; Usmani S; Durie BGM; Avet-Loiseau H; International Myeloma Working Group
Meeting abstract: BLOOD. 2013;122(21):920

Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis

Sahebi F; Iacobelli S; Van Biezen A; Volin L; Dreger P; Michallet M; Ljungman PT; Gahrton G; Morris CTCM; Schonland S; de Witte T; Garderet L; Kroeger N; Henseler A; Schaap NPM; Caballero D; Poire X; Passweg J; Hamljadi R-M
Review: LEUKEMIA. 2013;27(4):780-791

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Fernández de Larrea C; Kyle RA; Durie BGM; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; LeLeu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist U-H; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Bladé J; Orlowski RZ; Shah JJ; International Myeloma Working Group
Letter: MEDICAL ONCOLOGY. 2013;30(2):569

In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidéne et al.

Sutlu T; Alici E; Gahrton G; Nahi H
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(20):2475-2482

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Garderet L; Iacobelli S; Moreau P; Dib M; Lafon I; Niederwieser D; Masszi T; Fontan J; Michallet M; Gratwohl A; Milone G; Doyen C; Pegourie B; Hajek R; Casassus P; Kolb B; Chaleteix C; Hertenstein B; Onida F; Ludwig H; Ketterer N; Koenecke C; van Os M; Mohty M; Cakana A; Gorin NC; de Witte T; Harousseau JL; Morris C; Gahrton G
Letter: CANCER GENETICS. 2012;205(6):338-339

Historical note on the discovery of the Philadelphia chromosome.

Gahrton G
Other: MOLECULAR THERAPY. 2012;20(6):1084-1094

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Corrigan-Curay J; Cohen-Haguenauer O; O'Reilly M; Ross SR; Fan H; Rosenberg N; Somia N; King N; Friedmann T; Dunbar C; Aiuti A; Naldini L; Baum C; von Kalle C; Kiem H-P; Montini E; Bushman F; Sorrentino BP; Carrondo M; Malech H; Gahrton G; Shapiro R; Wolff L; Rosenthal E; Jambou R; Zaia J; Kohn DB
Meeting abstract: BLOOD. 2011;118(21):877

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Morris C; Iacobelli S; Gahrton G; Garderet L; Drake M; van Biezen A; Mohty M; Blaise D; Poire X; Kersten MJ; Milpied N-J; Lenhoff S; Russell NH; Finke J; de Witte TM
Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(2):137-147

Clinical impact of chromosomal aberrations in multiple myeloma.

Nahi H; Sutlu T; Jansson M; Alici E; Gahrton G
Review: CURRENT GENE THERAPY. 2010;10(6):414-422

Relevance of an academic GMP Pan-European vector infra-structure (PEVI).

Cohen-Haguenauer O; Creff N; Cruz P; Tunc C; Aïuti A; Baum C; Bosch F; Blomberg P; Cichutek K; Collins M; Danos O; Dehaut F; Federspiel M; Galun E; Garritsen H; Hauser H; Hildebrandt M; Klatzmann D; Merten OW; Montini E; O'Brien T; Panet A; Rasooly L; Scherman D; Schmidt M; Schweitzer M; Tiberghien P; Vandendriessche T; Ziehr H; Ylä-Herttuala S; von Kalle C; Gahrton G; Carrondo M
Review: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(29):4521-4530

International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.

Lokhorst H; Einsele H; Vesole D; Bruno B; San Miguel J; Pérez-Simon JA; Kröger N; Moreau P; Gahrton G; Gasparetto C; Giralt S; Bensinger W; International Myeloma Working Group
Review: LEUKEMIA. 2010;24(10):1700-1712

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.

Terpos E; Dimopoulos MA; Sezer O; Roodman D; Abildgaard N; Vescio R; Tosi P; Garcia-Sanz R; Davies F; Chanan-Khan A; Palumbo A; Sonneveld P; Drake MT; Harousseau J-L; Anderson KC; Durie BGM; International Myeloma Working Group
Review: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;85(4):279-289

Progress in allogeneic transplantation for multiple myeloma.

Gahrton G
Review: LEUKEMIA. 2010;24(6):1121-1127

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Kyle RA; Durie BGM; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M; International Myeloma Working Group
Meeting abstract: BLOOD. 2009;114(22):27

Tandem Autologous(ASCT)/Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT

Gahrton G; Bjorkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D
Review: LEUKEMIA. 2009;23(10):1716-1730

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.

Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BGM; Lonial S; IMWG
Review: LEUKEMIA. 2009;23(9):1545-1556

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BGM; IMWG
Other: JOURNAL OF INTERNAL MEDICINE. 2009;265(5):618-619

Professor Lars Erik Bottiger, in memoriam (1924-2009)

de Faire U; Fagrell B; Holm G; Gahrton G; Hallberg L
Review: LEUKEMIA. 2009;23(2):215-224

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BGM; International Myeloma Working Group
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(2):266-268

The prognostic significance of 8p21 deletion in multiple myeloma.

Sutlu T; Alici E; Jansson M; Wallblom A; Dilber MS; Gahrton G; Nahi H
Editorial comment: HAEMATOLOGICA. 2008;93(9):1295-1300

Allogeneic transplantation in multiple myeloma.

Gahrton G; Björkstrand B
Editorial comment: LEUKEMIA. 2008;22(8):1479-1484

The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.

Hussein MA; Vrionis FD; Allison R; Berenson J; Berven S; Erdem E; Giralt S; Jagannath S; Kyle RA; LeGrand S; Pflugmacher R; Raje N; Rajkumar SV; Randall RL; Roodman D; Siegel D; Vescio R; Zonder J; Durie BGM; International Myeloma Working Group
Meeting abstract: BLOOD REVIEWS. 2007;21:S10-S12

Stem cell transplantation in multiple myeloma

Gahrton G
Corrigendum: LEUKEMIA. 2007;21(5):1134

International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)

Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Corrigendum: LEUKEMIA. 2006;20(12):2220

International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)

Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Published conference paper: HEMATOLOGY. 2005;10 Suppl 1:127-128

Role of stem cell transplantation in myeloma.

Gahrton G; Iacobelli S; Björkstrand B; Bourhis J; Corradini P; Crawley C; Morris C; Niederwieser D; European Group for Blood and Marrow Transplantatio
Meeting abstract: BLOOD. 2004;104(11):264A

Long term follow-up shows no clinical benefit for CD34⁺ selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma:: An EBMT phase III randomized study.

Bourhis JH; Bouko Y; Koscielny S; Greinix H; Derigs G; Salles G; Feremans W; Bakkus M; Apperley J; Samson D; Bjorkstrand B; Niederwieser D; Gahrton G; Pico JL; Goldschmidt H
Meeting abstract: BLOOD. 2004;104(11):430A

Disruption of the HEXB/ENC-1 antisense gene and identification of elevated ENC-1 expression in patients with Hairy Cell Leukemia

Lerner M; Hammarsund M; Sangfelt O; Zhu CY; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grander D; Corcoran M
Editorial comment: LANCET. 2004;364(9446):1648-1649

New therapeutic targets in multiple myeloma.

Gahrton G
Published conference paper: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2002;76 Suppl 1:384-385

Goals and activities of the WMDA. World Marrow Donor Association.

Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):359-367

Suicide gene therapy: possible applications in haematopoietic disorders.

Dilber MS; Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):327-328

Introduction.

Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2000;248(3):185-201

Progress in haematopoietic stem cell transplantation for multiple myeloma.

Gahrton G; Björkstrand B
Review: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 1999;30(2):173-180

High-dose treatment of multiple myeloma.

Gahrton G; Björkstrand B
Editorial comment: LANCET. 1999;353(9147):85-86

Treatment of multiple myeloma.

Gahrton G
Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;451:493-497

Gene marking and gene therapy in multiple myeloma.

Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CI
Editorial comment: ANNALS OF ONCOLOGY. 1997;8(3):219-221

Bone marrow and peripheral blood stem cell transplantation in multiple myeloma.

Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 1997;242:U2

International Society of Haematology (European and African Division) XIV Meeting - 30 August 4 September 1997 Stockholm, Sweden - Education Programme - President's message

Gahrton G
Letter: LANCET. 1996;348(9023):346

Graft-versus-myeloma effect.

Aschan J; Lönnqvist B; Ringdén O; Kumlien G; Gahrton G
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17 Suppl 3:S63-S64

Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.

Simonsson B; Oberg G; Björeman M; Björkholm M; Carneskog J; Gahrton G; Hast R; Karl H; Lanng-Nielsen J; Löfvenberg E; Malm C; Turesson I; Udén AM; Vilén L; Weis-Bjerrum O
Review: BONE MARROW TRANSPLANTATION. 1996;17(1):13-18

Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).

Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Review: WIENER MEDIZINISCHE WOCHENSCHRIFT. 1995;145(2-3):52-54

Autologous stem-cell transplantation in multiple myeloma.

Gahrton G
Show more

Employments

Professor Emeritus/Emerita, Department of Medicine, Huddinge, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, 1966

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI